- Medical School - Hacettepe University, Turkey (1986-1993)
- Other Post Graduate Training - Columbia University Mailman School of Public Health (2011-2013)
- Fellowship - Vanderbilt University Medical Center, Transplant Nephrology
- Fellowship - University of Alabama Medical Center Program (1998-2000), Nephrology
- Residency - Tulane Medical Center (1995-1998), Internal Medicine
Bekir Tanriover, M.D., M.P.H.
- Internal Medicine - Nephrology
- Kidney Transplant Medicine
- Kidney Transplant Evaluations
Bekir Tanriover, M.D., M.P.H., is an Assistant Professor in the Department of Internal Medicine in the Division of Nephrology at UT Southwestern. He specializes in the medical management of kidney transplantation.
After receiving his medical degree from Hacettepe University in Turkey, Dr. Tanriover completed a residency in internal medicine at Tulane University. He performed a fellowship in nephrology at the University of Alabama and a fellowship in renal transplantation at Vanderbilt University. He later completed a master’s degree in public health at Columbia University’s Mailman School of Public Health in the “Cost Effectiveness and Outcomes” tract.
Prior to joining the faculty of UT Southwestern, Dr. Tanriover was an Assistant Professor of Clinical Medicine at the Columbia University College of Medicine. He also previously held the position of Medical Director of Kidney-Pancreas Transplantation at Methodist Dallas Medical Center.
Dr. Tanriover’s research focuses on analysis of medical and financial outcomes of kidney transplant patients and dual organ allocation (combined liver-kidney transplantation). He also is interested in the cost effectiveness of kidney transplants in high-risk patients.
He is board certified in internal medicine and nephrology and a member of the American Society of Transplantation and the American Society of Nephrology.
Meet Dr. Tanriover
Kidney Transplant Specialist
Kidney transplantation has come a long way over the last few decades, but one thing remains the same – it takes a knowledgeable and experienced expert like Bekir Tanriover, M.D., M.P.H., to manage the complicated situations patients face before, during, and after their kidney transplant.
A transplant nephrologist, Dr. Tanriover evaluates advanced or end-stage kidney disease patients to determine if they are ready for transplant, based on well-defined protocols and other health factors that could affect their outcome. He presents patient cases to a selection committee that then determines if a patient should be added to the kidney transplant list.
In addition, Dr. Tanriover manages long-term immunosuppression medications of kidney transplant patients and other medical needs after transplant in coordination with their referring nephrologist.
He does all of this with heartfelt compassion and commitment to what’s best for each patient.
“Each situation is complicated and unique, but we’re talking about a person’s life, and we want to do everything we can to help them,” he says.
Dr. Tanriover is proud to be part of a team of physicians at UT Southwestern that is responsible for innovations that have become nationally accepted practice.
“We are always on the cutting edge,” Dr. Tanriover says. “We monitor details that are above and beyond the standard of care to make sure a transplanted kidney has every chance to succeed.”
- American Society of Transplantation (2004), Member
- American Society of Nephrology (2004), Member
- NIH-K12 Award 2011, National Institutes of Health
- CTSA Pilot Project Award 2012, Columbia University
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry.
Mohan S, Tanriover B, Ali N, Crew RJ, Dube GK, Radhakrishnan J, Hardy MA, Ratner LE, McClellan W, Cohen D American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Aug 12 8 2098-105
Donor-specific antibodies adversely affect kidney allograft outcomes.
Mohan S, Palanisamy A, Tsapepas D, Tanriover B, Crew RJ, Dube G, Ratner LE, Cohen DJ, Radhakrishnan J Journal of the American Society of Nephrology : JASN 2012 Dec 23 12 2061-71
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation.
Tanriover B, Mohan S, Cohen DJ, Radhakrishnan J, Nickolas TL, Stone PW, Tsapepas DS, Crew RJ, Dube GK, Sandoval PR, Samstein B, Dogan E, Gaston RS, Tanriover JN, Ratner LE, Hardy MA American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2014 Feb 14 2 404-15
Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S Transplantation 2014 Mar 97 6 642-7
Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation.
Ramanathan V, Goral S, Tanriover B, Feurer ID, Kazancioglu R, Shaffer D, Helderman JH Transplantation 2005 May 79 10 1453-8
Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction: a new look to combined liver kidney allocation in the post-MELD era.
Tanriover B, Mejia A, Weinstein J, Foster SV, Ghalib R, Mubarak A, Cheng SS Transplantation 2008 Dec 86 11 1548-53
Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
Tsapepas DS, Mohan S, Tanriover B, Dube G, Crew RJ, Cohen DJ, Hardy MA, Sandoval PR, Ratner LE Transplantation 2012 Aug 94 4 325-30
Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.
Nikkel LE, Mohan S, Zhang A, McMahon DJ, Boutroy S, Dube G, Tanriover B, Cohen D, Ratner L, Hollenbeak CS, Leonard MB, Shane E, Nickolas TL American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Mar 12 3 649-59
Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes.
Nikkel LE, Iyer SP, Mohan S, Zhang A, McMahon DJ, Tanriover B, Cohen DJ, Ratner L, Hollenbeak CS, Rubin MR, Shane E, Nickolas TL Kidney international 2013 Mar 83 3 471-8
Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States.
Tanriover B, Stone PW, Mohan S, Cohen DJ, Gaston RS Clinical journal of the American Society of Nephrology : CJASN 2013 Jul 8 7 1258-66
- Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry.
- Policy and Allocation in Dual Kidney Transplantation
- Cost-effectiveness and Outcomes in High Risk Deceased Donor Kidney Transplantation
- Kidney Transplant Medicine
- Kidney Transplant Evaluations
Q&A by Dr. Tanriover
Showing 2 locations
808 Joliet Ave., Suite 120
Lubbock, Texas 79415